Shanghai - Delayed Quote CNY

Harbin Pharmaceutical Group Co., Ltd. (600664.SS)

Compare
3.9600
-0.4400
(-10.00%)
At close: January 10 at 3:00:03 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Bo Jiang CFO & VP -- -- 1964
Mr. Xiaodong Meng VP & Secretary -- -- 1972
Mr. Haitao Jiang Vice President -- -- 1982
Mr. Jicheng Xia Vice President -- -- 1979
Mr. Bangdong Li Vice President -- -- 1973

Harbin Pharmaceutical Group Co., Ltd.

No. 7, Qunli Avenue
Daoli District
Harbin, 150070
China
86 45 1518 70240 https://www.hayao.com
Sector: 
Healthcare
Full Time Employees: 
9,853

Description

Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trading of pharmaceuticals in China and internationally. The company offers pharmaceutical products for blood and hematopoietic, antineoplastic and immunomodulatory, respiratory, anti-inflammatory and analgesic, and chronic diseases, as well as mineral supplements, Chinese medicines, and antibiotics. It offers its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. The company is based in Harbin, China.

Corporate Governance

Harbin Pharmaceutical Group Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 4, 2018 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers